P71 LEUKAEMIA INHIBITORY FACTOR PROTECTS CHOLANGIOCARCINOMA CELLS FROM CYTOTOXICITY VIA A STAT-3-INDEPENDENT, Mcl-1 ACTIVATION
Massimiliano Cadamuro(University of Padua), Luca Fabris(University of Padua), Marco Massani(AULSS 2 Marca Trevigiana), Tommaso Stecca(Ca' Foncello Hospital), Stuart Morton(University of Padua), Annarosa Floreani(University of Padua), Simone Brivio(University of Milano-Bicocca), N. Bassi(Ca' Foncello Hospital), Mario Strazzabosco(Smilow Cancer Hospital)
Cited by 0
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
|Nature Genetics|2013|398
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
|Journal of Hepatology|2016|344